乙酰肝素酶、MMP-9在膀胱移行细胞癌侵袭转移中的表达相关性及临床意义(3)
 |
| 第1页 |
参见附件。
[4] 曾轶晖.基因治疗胰腺癌的研究[J].中国医药导报杂志,2009,6(7):156-159.
[5] Gorogh T, Beier UH, Baumken J, et al. Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas [J]. Head Neck,2006,28(1):31-39.
[6] Baraz L, Haupt Y, Elkin M, et al. Tumor suppressor p53 regulates heparanase gene expression [J]. Oncogene,2006,25(28):3939-3947.
[7] Zhang S, Li L, Lin JY, et al. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma [J]. World J Gastroenterol,2003,9(5):899-904.
[8] 胡忠良,文继舫,沈明,等.TGIF,MMP9和蛋VEGF白在胃癌中的表达及临床病理联系[J].中南大学学报,2006,31(1):76-80.
[9] Matsumura S, One N, Nakayama H, et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer [J]. J Cancer Res Clin Oncol,2005,131(1):19-25.
[10] O'Grady A, Dunne C, O'Kelly P, et al. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression [J]. Histopathology,2007,51(6):793-804.
[11] 范钰,王崇强,张振水,等.基质金属蛋白酶7mRNA在胰腺癌组织中表达的临床意义[J].齐齐哈尔医学院学报,2008,29(1):4-6.
(收稿日期：2011-05-13)
您现在查看是摘要介绍页，详见PDF附件(1985kb)。